Laurence-Moon Syndrome: A Patient Guide
At a Glance
Laurence-Moon syndrome is a rare genetic condition caused by changes in PNPLA6 that can affect vision, movement, development, and pituitary hormones. Symptoms vary widely, so coordinated care from neurology, eye, endocrine, and genetics specialists is important.
Receiving a rare diagnosis can be overwhelming, especially when the medical terminology has changed over the years. Laurence-Moon syndrome is a rare, multi-system genetic condition that is now understood to be part of a broader family of disorders caused by pathogenic variants (mutations) in the PNPLA6 gene [1].
For many years, this condition was frequently confused or grouped with Bardet-Biedl syndrome (BBS) because both can affect vision and hormones [2]. However, modern genetics has clarified that Laurence-Moon syndrome is a distinct condition with its own unique biological cause: it involves reduced or abnormal function of an enzyme called neuropathy target esterase (NTE), which is vital for the health of your nervous system [3]. Because they are biologically different, features commonly seen in BBS—such as extra fingers or toes (polydactyly), early-onset obesity, or severe kidney disease—are not usually reported in Laurence-Moon syndrome [2]. However, if you do experience unexpected symptoms, they should always be evaluated by your doctor rather than dismissed.
Living with this syndrome generally means managing changes in three core areas: the eyes, the brain, and the endocrine (hormone) system. Most individuals experience a progressive breakdown of the light-sensing layers of the eye, known as chorioretinal dystrophy, which often begins with a loss of night or peripheral vision [4]. Over time, the condition may also affect movement and coordination, leading to balance issues (ataxia) or a stiffness in the legs (spasticity) [5]. Additionally, the pituitary gland may not produce enough hormones to trigger puberty or maintain adult energy and growth levels, a challenge that is often managed with hormone replacement therapy [6].
The progression of PNPLA6-related disorders is highly variable. While some individuals have symptoms that change very slowly and remain independently ambulatory well into adulthood, others may experience earlier or more severe developmental, neurological, visual, or pituitary involvement [3][7]. Reliable individual prognostic or survival estimates are currently unavailable due to the rarity of the condition.
Because the condition affects multiple parts of the body, the most effective approach involves a dedicated, multidisciplinary team of specialists—including neurologists, eye doctors, endocrinologists, and genetic counselors—who work together to monitor your health [1]. The focus of your care is on supportive management and maximizing your quality of life. By using modern tools like low-vision rehabilitation, physical therapy, and precisely tailored hormone support, you and your medical team can navigate the condition proactively [8].
In this guide
6 chapters
Understanding Your Laurence-Moon Syndrome Diagnosis
Learn how PNPLA6 shapes Laurence-Moon syndrome, how it differs from Bardet-Biedl syndrome, and which eye, nerve, hormone, and mobility issues to monitor.
Tracking Symptoms and Understanding Progression
Learn how Laurence-Moon syndrome may affect vision, balance, movement, and hormones over time, plus emergency warning signs and when to contact your care team.
The Biology and Genetics of Your Diagnosis
Learn how PNPLA6 variants cause Laurence-Moon syndrome, how autosomal recessive inheritance works, and what genetic testing can help confirm your diagnosis.
The PNPLA6 Family: Understanding the Spectrum
Learn how Laurence-Moon syndrome fits the PNPLA6 spectrum, comparing Boucher-Neuhäuser, Gordon-Holmes, Oliver-McFarlane, and SPG39 and guiding care decisions.
Treatment, Management, and Building Your Care Team
Learn how Laurence-Moon syndrome is managed, including vision support, physical therapy, hormone care, fertility planning, and specialist team coordination.
Looking Ahead: Monitoring and Long-Term Outlook
Learn how Laurence-Moon syndrome monitoring tracks vision, balance, hormones, and bone health, while explaining progression, prognosis, and emotional support.
Common questions in this guide
What causes Laurence-Moon syndrome?
How is Laurence-Moon syndrome different from Bardet-Biedl syndrome?
What vision problems can Laurence-Moon syndrome cause?
Can Laurence-Moon syndrome affect movement and hormones?
What treatments and support are available for Laurence-Moon syndrome?
What is the outlook for someone with Laurence-Moon syndrome?
Get notified when new evidence is published on Laurence-Moon syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
PNPLA6 disorders: what's in a name?
Liu J, Hufnagel RB
Ophthalmic genetics 2023; (44(6)):530-538 doi:10.1080/13816810.2023.2254830.
PMID: 37732399 - 2
Prenatal diagnosis of Bardet Biedl Syndrome: A case report.
Arora E, Fuks A, Meyer J, Chervenak J
Radiology case reports 2023; (18(1)):326-330 doi:10.1016/j.radcr.2022.10.040.
PMID: 36406960 - 3
Multifaceted and Age-Dependent Phenotypes Associated With Biallelic PNPLA6 Gene Variants: Eight Novel Cases and Review of the Literature.
Nanetti L, Di Bella D, Magri S, et al.
Frontiers in neurology 2021; (12()):793547 doi:10.3389/fneur.2021.793547.
PMID: 35069422 - 4
Novel variants in PNPLA6 causing syndromic retinal dystrophy.
Wu S, Sun Z, Zhu T, et al.
Experimental eye research 2021; (202()):108327 doi:10.1016/j.exer.2020.108327.
PMID: 33141049 - 5
Homozygous PNPLA6 Mutation (p.Arg1183Trp) Associated With Isolated Cerebellar Ataxia: A Familial Case Report.
Alawadhi A, Almarzooqi A, Khan M, Alrukn S
Cureus 2026; (18(4)):e107039 doi:10.7759/cureus.107039.
PMID: 42147656 - 6
New insights into Oliver-McFarlane syndrome: adrenocortical hypofunction and variable expressivity in a Chinese sibling pair.
Du C, Yu T, Liu S, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(6)):622-627 doi:10.1515/jpem-2025-0731.
PMID: 41846525 - 7
Oliver McFarlane syndrome: two new cases and a review of the literature.
Lisbjerg K, Andersen MKG, Bertelsen M, et al.
Ophthalmic genetics 2021; (42(4)):464-473 doi:10.1080/13816810.2021.1904419.
PMID: 33818269 - 8
Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders.
Liu J, He Y, Lwin C, et al.
Brain : a journal of neurology 2024; (147(6)):2085-2097 doi:10.1093/brain/awae055.
PMID: 38735647
This Laurence-Moon syndrome overview is for informational purposes only and does not constitute medical advice. Your multidisciplinary care team should interpret symptoms, treatment options, and emergency plans for your specific situation.